SEC Tracker
Get the app
ISRG · XBRL financial data

Intuitive Surgical financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal years (ISRG's year ends in late December)

In millions of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Revenue from contracts with customers4,3585,7106,2227,1248,35210,065
Cost of goods and services sold1,4971,7522,0262,3952,7183,422
Gross profit2,8613,9594,1964,7305,6346,642
Research and development5956718799991,1451,312
Selling, general and administrative1,2161,4671,7401,9642,1402,385
Total operating expenses1,8112,1382,6192,9633,2853,697
Operating income (loss)1,0501,8211,5771,7672,3492,946
Income tax expense (benefit)140162262142336435
Net income (loss)1,0611,7051,3221,7982,3232,856
Earnings per share, basic USD per share9.064.793.725.126.548.00
Earnings per share, diluted USD per share8.824.663.655.036.427.87
Weighted average shares, basic millions of shares117356356351355357
Weighted average shares, diluted millions of shares120366362357362363
  • † Share count changed about 3x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal years (ISRG's year ends in late December)

In millions of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Cash and cash equivalents1,6231,2911,5812,7502,0273,368
Marketable securities3,4892,9132,5372,4731,9862,567
Marketable securities, non-current1,7584,4162,6242,1204,8193,099
Accounts receivable6467839421,1301,2251,527
Inventory6025878931,2211,4871,840
Prepaid and other current assets268271300314385477
Total current assets6,6265,8456,2537,8887,1119,780
Property and equipment, net1,5771,8762,3743,5384,6475,342
Right-of-use asset64748279136151
Goodwill337344349349348370
Total assets11,16913,55512,97415,44218,74320,459
Accounts payable82121147189193255
Total current liabilities9651,1501,4221,6591,7452,006
Lease liability, non-current58677065113132
Total liabilities1,4101,6041,8612,0442,2142,517
Retained earnings3,2614,7613,5004,7436,8037,012
Total stockholders' equity9,73211,90111,04213,30816,43417,824
Total liabilities and equity11,16913,55512,97415,44218,74320,459
Common shares outstanding (cover page) millions of shares118358350352357355
  • † Share count changed about 3x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal years (ISRG's year ends in late December)

In millions of dollarsDec 31, 2020†Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025
Net income (loss)1,0611,7051,3221,7982,3232,856
Stock-based compensation395449513593677788
Net cash from operating activities1,4852,0891,4911,8142,4153,031
Net cash from investing activities(941)(2,462)1,371(360)(3,273)666
Share repurchases13402,60741602,295
Net cash from financing activities(86)43(2,572)(288)151(2,364)
Net change in cash456(333)2951,169(708)1,345
  • † Share count changed about 3x in the period ending 2021-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 3842 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen
  • SIC 3842 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
  • Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
  • Runway shows only for companies burning cash with under $10B of public float.
  • * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
  • A cell reading “not reported” means the filings give no figure for that quarter alone.
CompanyCash ($M)Revenue, quarter ($M)Operating cash flow, quarter ($M)Shares outstandingRunwayQuarter
Intuitive Surgical2,9783,0491,224*346.6M— 10-QSep 30, 2026
Boston Scientific6095,1381,048*1.4B— 10-QSep 30, 2026
Stryker3,2716,5201,461*380.7M— 10-QSep 30, 2026
Medtronic1,6919,7561,7931.3B— 10-QJul 31, 2026
3M4,8356,584486*516.7M— 10-QSep 30, 2026
Becton Dickinson7084,983not reported272.4M— 10-QJun 30, 2026
MiniMed Group207843(49)281.3M2.3 quarters 10-QJul 31, 2026
Edwards Lifesciences2,9071,741652*576.4M— 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.